北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study
作者: Yang, Wenying1; Gao, Yan2; Liu, Guoliang3; Chen, Lulu4; Fu, Zuzhi5; Zou, Dajin6; Feng, Ping7; Zhao, Zhigang8
关键词: BIAsp 30 ; China ; Observational study ; Routine practice
刊名: CURRENT MEDICAL RESEARCH AND OPINION
发表日期: 2010
DOI: 10.1185/03007990903364640
卷: 26, 期:1, 页:101-107
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal ; Medicine, Research & Experimental
研究领域[WOS]: General & Internal Medicine ; Research & Experimental Medicine
关键词[WOS]: DIABETIC-PATIENTS ; TYPE-2 ; RISK ; PREVALENCE
英文摘要:

Aims: To explore safety and efficacy of BIAsp 30 as initiation or replacement therapy in routine clinical practice in patients with poorly controlled diabetes in the Chinese cohort of the IMPROVE study.

Methods: In the 26-week, non-interventional, observational study, Chinese subjects with diabetes started BIAsp 30 treatment in routine care. Data from patients′ diaries and medical records were transferred to CRFs by participating physicians.

Clinical trial registration: NCT00659282.

Results: Of the 21,729 subjects enrolled (mean age 54.0 years, BMI 24.6 kg/m(2), diabetes duration 4.86 years), 32.3% were treatment-naive, 59.3% were from oral anti-diabetic drugs (OADs) only and 8.1% were from insulin +/- OADs. Overall, mean HbA(1c) and FBG decreased by 2.82% and 5 mmol/L, respectively. In the subgroups, changes were: -3.27% and -6.06 mmol/L (treatment-naive), -2.57% and -4.54 mmol/L (OADs only), -2.96% and 3.51 mmol/L (insulin +/- OADs) all p < 0.05. HbA(1c)< 7% was achieved by 71.4% of patients. Only 0.1% of subjects reported major hypoglycaemia and 73 SADRs were observed without significant difference compared to those at baseline. Body weight did not change significantly.

Conclusions: Regardless of previous treatments, insulin initiation or replacement with BIAsp 30 improved glycaemic control without increasing major hypoglycaemia or weight gain in Chinese patients with diabetes.

语种: 英语
项目资助者: Novo Nordisk
WOS记录号: WOS:000273417900012
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65120
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
2.Huazhong Technol Univ, Union Hosp, Wuhan, Peoples R China
3.Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China
4.Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
5.Peking Univ, Affiliated Hosp 1, Beijing 100871, Peoples R China
6.China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China
7.Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
8.Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China

Recommended Citation:
Yang, Wenying,Gao, Yan,Liu, Guoliang,et al. Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study[J]. CURRENT MEDICAL RESEARCH AND OPINION,2010,26(1):101-107.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yang, Wenying]'s Articles
[Gao, Yan]'s Articles
[Liu, Guoliang]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yang, Wenying]‘s Articles
[Gao, Yan]‘s Articles
[Liu, Guoliang]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace